Literature DB >> 32253007

Corona Virus: Global Pandemic Causing World-Wide Shutdown.

Edith P Mitchell1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32253007      PMCID: PMC7128812          DOI: 10.1016/j.jnma.2020.03.015

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


× No keyword cloud information.
What do we know about this virus? What do physicians and other clinicians need to do? Where can one obtain the most reliable advice? Human coronaviruses constitute a large family of viruses that usually cause mild to moderate upper respiratory illnesses in people such as the common cold. Initial characterization of the coronavirus occurred in the 1960's when Tyrell and Bynoe described passage of a virus named B814 at the time, as a group of viruses causing a large proportion of respiratory tract infections in humans. Coronavirus infections have since been described in multiple animal species as well, including bats, camels, cattle, cats, chicken, dogs, pigs, rabbits, rats and turkeys. Bats account for the largest group of animal reservoirs. There are many, perhaps even hundreds of coronaviruses circulating in animals with what is occasional spread to humans and termed – spill over events, that then cause more serious illness in humans with worsened outcomes yielding significant morbidity and high mortality rates. Coronaviruses are medium sized positive stranded RNA viruses that are named for the crown-like characteristic structures seen in electron micrographs. The characteristic spikes are formed by heavily glycosolated S protein. Viral replication develops in the cytoplasm of infected cells budding into cytoplasmic vesicles from the endoplasmic reticulum resulting in cellular destruction and death. While many different coronaviruses exist, seven types are known to cause disease in humans. Four of these viruses 229E, OC43, NL63 and KHU have been associated with mild disease symptoms. Three of the viruses have been associated with causation of more severe illnesses and worse outcomes in humans. The first of these to appear was named Severe Acute Respiratory Syndrome (SARS) and was first reported in Asia in February 2003, although retrospectively it was present in 2002. It subsequently disappeared in 2004. This was followed by Middle East Respiratory Syndrome (MERS) which was first noted in Saudi Arabia in 2012 and is currently still found in camels. The third being COVID-19 and is caused by the SARS-COV-2 that was first described in Wuhan China in December, 2019. Among older adults, coronaviruses have been associated with acute exacerbations of chronic obstructive pulmonary disease and acute asthma events in both adults and children as well as community acquired pneumonia. Coronaviruses have also been associated with other diseases including enteric manifestations causing abdominal pain, diarrhea, nausea, and vomiting as well as other symptoms such as chills, fever, headache and myalgia. Other rare conditions including acute and chronic neurologic disease have been reported. As there is currently no available specific pharmacologic therapeutic or vaccine, supportive care is the mainstay of treatment. Preventive strategies are focused on infection control procedures such as washing hands, careful disposal of material containing nasal and oral secretions, and the use of disinfectants to clean frequently used surfaces. Strategies to prevent infection with the new coronavirus from World Health Organization (WHO) and the Center for Disease Control (CDC) recommend following these precautions for avoiding COVID-19: Avoid large events and mass gatherings. Avoid close contact (about 6 feet) with anyone who is sick or has symptoms. Keep distance between yourself and others if COVID-19 is spreading in your community, especially if you have a higher risk of serious illness. Wash your hands often with soap and water for at least 20 seconds, or use an alcohol-based hand sanitizer that contains at least 60% alcohol. Cover your mouth and nose with your elbow or a tissue when you cough or sneeze. Throw away the used tissue. Avoid touching your eyes, nose and mouth if your hands aren't clean. Avoid sharing dishes, glasses, bedding and other household items if you're sick. Clean and disinfect surfaces you often touch on a daily basis. Stay home from work, school and public areas if you're sick, unless you're going to get medical care. Avoid taking public transportation if you're sick. CDC doesn't recommend that healthy people wear a face mask to protect themselves from respiratory illnesses, including COVID-19. The CDC has produced multiple information and useful guidelines to facilitate care and prevention of corona viruses including: Symptoms Older Adults and Medical Conditions Prepare Your Family Resources for the Community Checklist for Older Persons People Who Are Higher Risk Interim Guidance for Businesses and Employers Keeping Workplaces, Homes, Schools or Commercial Establishments Safe Information for Health Care Professionals Information for Healthcare Facilities Information for Health Departments Information for Laboratories Continuous Email Updates. It is so important that we in the National Medical Association maintain ongoing updates and information for our own and family care, our patients, our communities and our nation. Get the latest public health information from CDC: https://www.coronavirus.gov. Get the latest research information from NIH: https://www.nih.gov/coronavirus. The Publisher of Journal of the National Medical Association, Elsevier, has compiled an extensive list of publications that may also be useful to physicians and other clinicians and can be found at: Elsevier's Novel Coronavirus Information Center.
  8 in total

1.  History and recent advances in coronavirus discovery.

Authors:  Jeffrey S Kahn; Kenneth McIntosh
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

2.  Cultivation of viruses from a high proportion of patients with colds.

Authors:  D A Tyrrell; M L Bynoe
Journal:  Lancet       Date:  1966-01-08       Impact factor: 79.321

Review 3.  Genetic and molecular biological analysis of protein-protein interactions in coronavirus assembly.

Authors:  Paul S Masters; Lili Kuo; Rong Ye; Kelley R Hurst; Cheri A Koetzner; Bilan Hsue
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  A previously undescribed coronavirus associated with respiratory disease in humans.

Authors:  Ron A M Fouchier; Nico G Hartwig; Theo M Bestebroer; Berend Niemeyer; Jan C de Jong; James H Simon; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-08       Impact factor: 11.205

5.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia.

Authors:  Ali M Zaki; Sander van Boheemen; Theo M Bestebroer; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  N Engl J Med       Date:  2012-10-17       Impact factor: 91.245

6.  Pathogen spillover in disease epidemics.

Authors:  Alison G Power; Charles E Mitchell
Journal:  Am Nat       Date:  2004-11       Impact factor: 3.926

7.  Global patterns in coronavirus diversity.

Authors:  Simon J Anthony; Christine K Johnson; Denise J Greig; Sarah Kramer; Xiaoyu Che; Heather Wells; Allison L Hicks; Damien O Joly; Nathan D Wolfe; Peter Daszak; William Karesh; W I Lipkin; Stephen S Morse; Jonna A K Mazet; Tracey Goldstein
Journal:  Virus Evol       Date:  2017-06-12

8.  Seroepidemiologic studies of coronavirus infection in adults and children.

Authors:  K McIntosh; A Z Kapikian; H C Turner; J W Hartley; R H Parrott; R M Chanock
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

  8 in total
  4 in total

1.  Knowledge, attitudes and practices of Iranian people about food safety and hygiene during covid-19 pandemic.

Authors:  Ali Salehi; Fatemeh Salmani; Ensiyeh Norozi; Parisa Sadighara; Tayebeh Zeinali
Journal:  BMC Public Health       Date:  2022-06-08       Impact factor: 4.135

Review 2.  Impact of repurposed drugs on the symptomatic COVID-19 patients.

Authors:  Iqbal Hussain; Afzal Hussain; Mohamed F Alajmi; Md Tabish Rehman; Samira Amir
Journal:  J Infect Public Health       Date:  2020-12-07       Impact factor: 3.718

3.  A hybrid computational framework for intelligent inter-continent SARS-CoV-2 sub-strains characterization and prediction.

Authors:  Moses Effiong Ekpenyong; Mercy Ernest Edoho; Udoinyang Godwin Inyang; Faith-Michael Uzoka; Itemobong Samuel Ekaidem; Anietie Effiong Moses; Martins Ochubiojo Emeje; Youtchou Mirabeau Tatfeng; Ifiok James Udo; EnoAbasi Deborah Anwana; Oboso Edem Etim; Joseph Ikim Geoffery; Emmanuel Ambrose Dan
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

Review 4.  Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.

Authors:  Rohan Narayan; Shashank Tripathi
Journal:  Front Cell Infect Microbiol       Date:  2020-10-02       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.